ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $62.5B | −0.8% | −5.4% | 8.2% |
| Long-term debt (Q2 2026) | $62.5B |
|---|---|
| YoY | −0.8% |
| 5-year CAGR | −5.4% |
| 10-year CAGR | 8.2% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $64.5B | −3.5% |
| 2024 | $66.8B | +12.8% |
| 2023 | $59.2B | −6.2% |
| 2022 | $63.1B | −16.9% |
| 2021 | $76.0B | −10.6% |
| 2020 | $84.9B | +26.3% |
| 2019 | $67.2B | +92.1% |
| 2018 | $35.0B | +13.1% |
| 2017 | $31.0B | −15.1% |
| 2016 | $36.4B | +24.6% |
| 2015 | $29.2B | +177.5% |
| 2014 | $10.5B | −26.3% |
| 2013 | $14.3B | −2.3% |
| 2012 | $14.6B | — |